Genetic control of anticoagulation

Lancet. 1999 Feb 27;353(9154):688-9. doi: 10.1016/S0140-6736(98)00326-2.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants / adverse effects*
  • Aryl Hydrocarbon Hydroxylases*
  • Cytochrome P-450 Enzyme System / genetics*
  • Hemorrhage / chemically induced
  • Hemorrhage / genetics*
  • Humans
  • International Normalized Ratio
  • Point Mutation
  • Steroid 16-alpha-Hydroxylase*
  • Steroid Hydroxylases / genetics*
  • Warfarin / adverse effects*

Substances

  • Anticoagulants
  • Warfarin
  • Cytochrome P-450 Enzyme System
  • Steroid Hydroxylases
  • Aryl Hydrocarbon Hydroxylases
  • Steroid 16-alpha-Hydroxylase